Cambrex Breaks Ground on $120M Iowa Expansion Adding 160,000 Liters
Image
East Rutherford – October 30, 2026 -- Cambrex has started construction on a $120 million expansion at its Charles City, Iowa, facility, adding 160,000 liters of manufacturing capacity for small molecule active pharmaceutical ingredients (APIs) and synthetic peptides.
Expansion lifts Charles City capacity by about 25% to nearly one million liters
The contract development and manufacturing organization (CDMO) expects to complete the project in the fourth quarter of 2028. The added volume raises the site's total capacity by approximately 25%, to nearly one million liters.
Cambrex held a groundbreaking ceremony on October 29 with company leaders, employees, state and local officials and members of the Charles City community. The start of construction coincides with the site's 100th anniversary.